A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this study is to examine the effect of 400 mg of oral zinc gluconate on genital warts. Our hypothesis is that there will be a 10% difference in complete clearance of genital warts in the group randomized to oral plus standard of care compared to those randomized to placebo plus standard of care.
Epistemonikos ID: bc19f20dcd68cf63cd9bf1748e085db3212e7e75
First added on: May 10, 2024